Xconomy

DECEMBER 20, 2018

New biopharma company Aristea Therapeutics has raised $15 million from Novo Holdings, the Danish investment company, and secured global rights to an investigational AstraZeneca drug that’s ready for Phase 2 study. The San Diego, CA, company made its public debut this week after starting up quietly earlier this year.

Develop 67

Develop Development San Diego Study 67

Xconomy

OCTOBER 10, 2017

The San Diego artificial intelligence company Brain Corp. topped the chart for raising the most venture capital in San Diego during the third quarter that ended September 30, according to Venture Monitor data released Tuesday. Altogether, venture firms invested. As Xconomy reported in July, Brain Corp.

San Diego 48

San Diego Venture Capital Artificial Inteligence Funding 48

Both Sides of the Table

OCTOBER 19, 2009

On December 2nd, 2006 I wrote the blog post published later in this post when I was CEO of startup Koral about my experiences in pitching VCs. After my company was acquired by Salesforce.com I was asked to stop blogging and they took over my blog as an asset in the sale of the company. My blog was wiped out.

Venture Capital 274

Venture Capital Blogging Startup Slides 274

Xconomy

JULY 17, 2016

After the national MoneyTree Report was released last week, PricewaterhouseCoopers partner Ryan Spencer said he spent time on a call with Thomson Reuters, which provides the raw data, trying to figure out a change in the numbers for venture capital activity in San Diego. But the San Diego data was off. So the $350.5

San Diego 40

San Diego Venture Capital Funding Report 40

Xconomy

SEPTEMBER 11, 2019

Avalon said Tuesday that GSK (NYSE: GSK ) has agreed to buy the company, Sitari Pharmaceuticals, which has been developing a treatment for celiac disease. Sitari was the first of eight companies spun up through the partnership between the Southern California investment outfit and British pharma company.

Avalon 56

Avalon Invest Southern California Develop 56

Xconomy

NOVEMBER 13, 2016

I started with a list of companies already screened by the San Diego Venture Group’s annual venture summit, and consulted with investors and startup mentors to refine the list. million in a Series D round of investment capital, according to founder and chairman Tony Farwell. Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 40

San Diego Technical Review Artificial Inteligence Startup 40

Xconomy

MARCH 15, 2019

A global pharmaceutical company based in France has licensed software developed by San Diego digital health startup CureMatch that aims to help cancer doctors customize the combination of drugs they prescribe to patients based on mutations in cancer DNA. The company, which CEO Bob Manning says has raised about $2.5

Customer 76

Customer Custom San Diego Guide 76

Xconomy

JANUARY 9, 2020

Empirico, a biotech that has developed tools to analyze genomics data and use those insights to identify potential therapeutic targets, has signed a collaboration deal with antisense drug developer Ionis Pharmaceuticals that includes a $10 million equity investment.

San Diego 98

San Diego Equity Tool Platform 98

Xconomy

MARCH 5, 2018

Vividion Therapeutics is partnering with Celgene to develop new drugs that modulate protein levels as a way of treating disease. Celgene (NASDAQ: CELG ) will pay San Diego-based Vividion $101 million up front, which includes an equity investment. Read more » Reprints | Share:

Develop 45

Develop Development San Diego Equity 45

Xconomy

APRIL 3, 2019

A 25-person startup developing advanced computing tools to speed up pathology work has raised its first institutional financing from a group of investors led by Intel Capital, the corporate investment arm of the chipmaker. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Artificial Inteligence 101

Artificial Inteligence San Diego Tool Invest 101

Xconomy

DECEMBER 19, 2018

Louis, MO-based venture capital firm with additional offices in San Diego, CA, and Cleveland, OH, has raised $184.4 million for its fourth fund dedicated to investing in healthcare companies. Since its launch, RiverVest has invested in 47 companies working to develop new drugs and medical devices.

San Diego 107

San Diego Funding Venture Capital Invest 107

Xconomy

APRIL 22, 2019

Swiss pharma giant Novartis has invested $75 million in a $142 million Series C round for San Diego-based Poseida, which is one of several companies developing what is meant to be a one-time, long-lasting treatment for multiple myeloma.

San Diego 83

San Diego Study Funding Invest 83

Xconomy

FEBRUARY 13, 2019

TuSimple has pulled in $95 million more in venture funding to advance its development of a commercial autonomous fleet of trucks. TuSimple, founded in 2015 in San Diego and Beijing, raised its Series C round of $55 million in late 2017. Composite Capital , a Hong Kong-based investment fund started in 2016, led that round.

San Diego 74

San Diego Company Companies Funding 74

socalTECH

OCTOBER 19, 2011

Fullerton-based Hipgeo , the developers of iPhone apps for tracking and logging your travels, said today that it has launched a new version of its product which is specifically aimed at travelers. READ MORE>>.

eHarmony 154

eHarmony Yahoo San Diego Blogging 154

Xconomy

MARCH 25, 2019

A program launched last year by the Wisconsin Alumni Research Foundation to invest in promising biotech discoveries made on the University of Wisconsin-Madison campus will also work with the La Jolla, CA-based Sanford Burnham Prebys Medical Discovery Institute, the organizations said recently.

San Diego 107

San Diego Research Organization Invest 107

Xconomy

FEBRUARY 6, 2020

This is the last week to register at the lowest rate for March 18’s Xcelerating Life Sciences: Biomedical Breakthroughs in Precision Medicine & Genomics conference at the Takeda Research facility in San Diego. Hurry, our $99 early bird sale ends this Friday, Feb. 7 at midnight. Speakers include Jay Lichter, CEO of.

Conference 49

Conference San Diego Sales Research 49

Xconomy

JANUARY 9, 2020

San Diego startup DTx Pharma has raised $10.6 million to advance technology it has developed that uses fatty acids in an effort to overcome delivery and distribution issues. The sum includes an undisclosed amount from Eli Lilly (NYSE: LLY ), which has made a number of investments in biotechs pursuing RNA-focused technologies.

San Diego 68

San Diego Invest Technology Startup 68

Xconomy

DECEMBER 18, 2018

A year after steering cancer drug developer Ignyta into a $1.7 Ignyta’s former co-founder and head executive has co-founded another biotech in San Diego, Erasca, which also wants to make new cancer therapies. billion sale to Roche , Jonathan Lim is back at it again.

San Diego 86

San Diego Startup Sales Invest 86

Xconomy

JUNE 18, 2020

Typically a new biotech assembles a group of investors that collectively puts in the money a fledgling company requires to develop or acquire potential therapies.

Develop 77

Develop Development Funding San Diego 77

Xconomy

AUGUST 22, 2016

In downtown San Diego, a private real estate company best known for its master-planned communities in suburban Southern California has posed some existential questions for regional tech hubs looking to build their own startup ecosystems. 101 West Broadway tower in downtown San Diego. John “J.T.”

Develop 40

Develop Development San Diego Startup 40

Xconomy

JANUARY 16, 2019

Billions of dollars have already flowed to the purveyors of shared workspaces, and the investment spigot isn’t turning off yet. Read more » Reprints | Share:

San Diego 79

San Diego Education Invest Sites 79

Xconomy

MARCH 7, 2019

Chinese pharma company BeiGene has agreed to pay Ambrx $10 million upfront to experiment with technology the biotech has developed in a bid accelerate BeiGene’s search for new protein drugs for cancer treatment. Ambrx says its technology is able to incorporate “non-natural” amino acids into cells like E.

Develop 79

Develop Development Technology Product 79

Xconomy

SEPTEMBER 27, 2017

San Antonio — A biomedical product developer, Watershed Idea Foundry, has created a method of identifying medical devices that have been implanted in the body that uses 3-D printing and its own software.

Develop 108

Develop Development Incubator Ideas 108

Xconomy

MARCH 22, 2019

Turning Point Therapeutics, which is developing targeted cancer drugs for patients whose tumors resist other precision therapies, has outlined plans for an IPO. The company, which started operations in 2014, has raised nearly $148 million since inception. Drugs already exist for some cancers associated with those.

San Diego 88

San Diego Develop Development Company 88

Xconomy

MARCH 16, 2018

There’s never a dull moment these days at Building N, the San Diego headquarters of Qualcomm (NASDAQ: QCOM ), the wireless technology giant and the world’s biggest maker of the advanced components used in smartphones. [ Updated 3/16/18 3:30 pm. Updated with Qualcomm board announcement. ]

San Diego 45

San Diego Develop Development Technology 45

Xconomy

MAY 16, 2019

BioClarity, which sells plant-based skincare products to online shoppers, announced Wednesday that it has raised a $13 million investment round. The San Diego-based company is part of Adigica Health, an e-commerce company founded in 2016 to develop and market direct-to-consumer healthcare products.

Product 58

Product San Diego Commerce Invest 58

Xconomy

SEPTEMBER 19, 2019

The San Diego-based biotech came out of stealth mode Thursday with an announcement that it had raised a $46.4 million Series A financing round to fund the development of cancer drugs targeting tumors that have what’s known as extrachromosomal DNA. Zach Hornby, former chief.

San Diego 102

San Diego Funding Develop Development 102

Xconomy

OCTOBER 19, 2018

The San Diego-based biotech, which is developing targeted cancer drugs for people whose tumors resist other precision therapies, announced the changes Friday. Five-year-old biotech TP Therapeutics has raised an $80 million mezzanine financing round and promoted its chief medical officer, Athena Countouriotis, to CEO.

San Diego 97

San Diego Develop Development Venture Capital 97

Xconomy

JUNE 27, 2018

Sales of Cibus’ first product, a gene-edited canola, have gone so well that the San Diego company has raised $70 million in new financing to boost its commercialization efforts. Cibus’s first commercial product is SU Canola, a variety of canola that is tolerant to sulfonylurea, a type of herbicide.

San Diego 61

San Diego Marketing Research Invest 61

Xconomy

OCTOBER 22, 2018

San Diego-based Qpex has raised $33 million to advance The Medicines Company’s (NASDAQ: MDCO ) old preclinical compounds toward human testing. That company was developing. The Medicines Company exited the infectious disease business last year when it sold three bacteria-fighting products to Melinta Therapeutics.

San Diego 86

San Diego Company Companies Develop 86

Xconomy

JANUARY 4, 2019

When it comes to developing and promoting innovation, external factors beyond the control of company founders, investors, and other business leaders can also determine whether a startup succeeds or fails. Xconomy: Has the Trump era been good or bad for your company? Manoj Saxena , CognitiveScale chairman. Read more » Reprints | Share:

San Diego 102

San Diego .Net Startup Develop 102

Xconomy

OCTOBER 1, 2018

VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The company is developing antibody drug conjugates, a class of cancer drug that links antibodies to potent cancer-fighting toxins. The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX ) and Sofinnova Ventures.

San Diego 91

San Diego Incubator Class Study 91

Xconomy

DECEMBER 24, 2018

Now, the San Diego-based startup is looking to Wall Street for additional funds. The company last Friday outlined plans for an initial public offering to advance its development of immunology, inflammation, and oncology drugs. Seven months later, it tacked on another $230 million. Gossamer wants to raise $264.5

San Diego 80

San Diego Funding Startup Marketing 80

Xconomy

JUNE 30, 2016

Healthtech entrepreneur Parker Hinshaw and his wife Jean Balgrosky said they intended to take a step back when they founded Bootstrap Incubation near San Diego in the fall of 2012. They came to San Diego in 1996, when Scripps Health hired Balgrosky as CIO and senior vice president. He founded MaxIT Healthcare in 2001.

San Diego 67

San Diego Incubator CIO Startup 67

Xconomy

AUGUST 17, 2016

Histogen, a San Diego-based regenerative medicine company with technology for growing skin cells and related products, said it has raised $6 million from an affiliate of Huapont Life Sciences, a healthcare products company based in Chongqing, China.

Invest 40

Invest San Diego Journal Technical Review 40

Xconomy

FEBRUARY 15, 2017

Liver disease is challenging for doctors because it can develop without symptoms, making diagnosis difficult without removing cells for examination. For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

AUGUST 30, 2017

Investment in experimental drugs for hearing loss, long an untapped field in the pharmaceutical industry, may be picking up, but drugs that actually help with these disorders remain elusive. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 59

San Diego Invest Help Develop 59